查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496277

非处方避孕药市场 - 全球产业规模、份额、趋势、机会和预测，按药丸类型、类别、配销通路、地区和竞争细分，2019-2029F

Over the Counter Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Pill Type, By Category, By Distribution Channel, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2023 年全球非处方 (OTC) 避孕药市场规模为 160.9 亿美元，预计在预测期内将强劲增长，到 2029 年复合年增长率为 8.54%。分销避孕药的经济部门，无需处方即可直接向消费者提供避孕药。这些药丸含有避孕激素，在世界各地被用作避孕方法。该市场的特点是影响其成长的因素众多，例如政府政策、社会接受度、公众对可及性的认识以及製药技术的进步。随着人们对生殖健康和权利的日益关注，这个市场有望扩大，因为它满足了对方便和私人获得节育方法的需求。

市场概况
预测期 2025-2029
2023 年市场规模 160.9亿美元
2029 年市场规模 262亿美元
2024-2029 年复合年增长率 8.54%
成长最快的细分市场 复方药丸
最大的市场 北美洲

主要市场驱动因素

提高意识和教育

不断增加的文化转变和态度

政府配套政策法规

电子商务和线上药局激增

主要市场挑战

仿冒品

定价压力

主要市场趋势

持续研究及新产品开发

线上咨询服务和远距医疗日益普及

细分市场洞察

药丸类型见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：Covid-19 对全球非处方 (OTC) 避孕药市场的影响

第 4 章：执行摘要

第 5 章：客户之声

第 6 章：全球非处方 (OTC) 避孕药市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按药丸类型（孕激素药丸和复方药丸）
    • 按类别（通用和品牌）
    • 按配销通路（线下和线上）
    • 按地区
    • 按公司划分 (2023)
  • 市场地图

第 7 章：北美非处方 (OTC) 避孕药市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按药丸类型
    • 按类别
    • 按配销通路
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 8 章：欧洲非处方 (OTC) 避孕药市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按药丸类型
    • 按类别
    • 按配销通路
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 英国

第 9 章：亚太地区非处方 (OTC) 避孕药市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按药丸类型
    • 按类别
    • 按配销通路
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 10 章：中东和非洲非处方 (OTC) 避孕药市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按药丸类型
    • 按类别
    • 按配销通路
    • 按国家/地区
  • 中东和非洲：国家分析
    • 阿联酋
    • 沙乌地阿拉伯
    • 南非

第 11 章：南美洲非处方 (OTC) 避孕药市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按药丸类型
    • 按类别
    • 按配销通路
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 12 章：市场动态

  • 司机
  • 挑战

第 13 章：市场趋势与发展

  • 併购（如有）
  • 产品发布（如有）
  • 最近的发展

第 14 章：全球非处方 (OTC) 避孕药市场：SWOT 分析

第 15 章：杵分析

第16章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第17章：竞争格局

  • Mylan NV
  • Nurx Inc.
  • Everly Well, Inc.
  • Letsgetchecked Inc.
  • Uqora, Inc.
  • Hims & Hers Health, Inc.
  • Lemonaid Health, Inc.
  • Perrigo Company plc

第 18 章：策略建议

第19章调查会社について・免责事项

简介目录
Product Code: 23813

Global Over the Counter (OTC) Contraceptive Pills Market stood at USD 16.09 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.54% through 2029. The Global Over the Counter (OTC) Contraceptive Pills Market refers to the economic sector that deals with the sale and distribution of birth control pills available directly to consumers without a prescription. These pills contain hormones that prevent pregnancy and are used worldwide as a method of contraception. The market is characterized by numerous factors that influence its growth, such as government policies, societal acceptance, public awareness of accessibility, and advancements in pharmaceutical technology. With an increasing focus on reproductive health and rights, this market is poised to expand as it responds to the demand for convenient and private access to birth control methods.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 16.09 Billion
Market Size 2029USD 26.20 Billion
CAGR 2024-20298.54%
Fastest Growing SegmentCombination Pills
Largest MarketNorth America

Key Market Drivers

Increased Awareness & Education

One of the most important factors influencing Over the Counter (OTC) Contraceptive Pills market is increased awareness and education. Through awareness campaigns and educational programs, more women become aware of the different types of contraception available to them. As a result, they become more aware of the benefits and significance of contraception in preventing unwanted pregnancies and improving overall health. By educating women about contraception methods, including Over the Counter (OTC) Contraceptive Pills, myths and misperceptions about birth control are reduced, leading to less stigma and more acceptance. As more women learn about different contraceptive methods, they're more likely to see OTC Pills as a good option, especially for women who want to remain in control of their reproductive choices without frequent doctor visits.

In addition, women are better able to make informed decisions about their reproductive health because healthcare providers and organizations provide comprehensive educational campaigns. Women learn about the effectiveness of OTC contraceptives, side effects and how to use them correctly, allowing them to choose the best option based on their needs and preferences. The effects of increased awareness also extend to social attitudes. With more open and supportive conversations about family planning, women feel more confident to talk about contraception and access methods. This shift in culture reduces obstacles to taking over-the-counter contraceptive Pills and promotes responsible use.

The Over the Counter (OTC) Contraceptive Pills market is positively impacted by increased awareness and education, which allows women to make informed reproductive health decisions. As awareness of family planning increases, more women see and accept OTC contraception Pills as an easy and effective way to responsibly manage their reproductive choices. This results in boosting the demand for Over the Counter (OTC) market increases in the forecast period.

Increasing Culture Shifts & Attitudes

The OTC contraceptive pill market is driven by cultural shifts and attitudes. As social norms change, conversations about reproductive health become more inclusive and less stigmatized. This cultural shift creates a space where women feel more confident and empowered to explore various forms of contraception, including Over the Counter (OTC) Contraceptive Pills. As cultural attitudes change, the image of family planning changes from one that is seen as taboo to one that is embraced and supported.

In addition, as women and men talk more openly about their reproductive options, the value of affordable and easy-to-use methods of contraception is becoming increasingly clear. OTC methods of contraception, with their convenience and discreet use, respond to the changing culture and appeal to people who value autonomy and decision-making when it comes to family planning. A survey last year by KFF (Kaiser Family Foundation), found that more than four-in-five women of reproductive age say they prefer an OTC pill, mainly because it's easier to take. Almost 40 percent said they'd be likely to use the product. The survey found that women who are already taking a birth control pill, women who don't have health insurance and women who are Hispanic were the most likely to use an OTC pill.

Also, as cultural beliefs and practices focus more on gender roles and women's empowerment, there's a growing need for contraception options that allow women to make better decisions about their bodies. OTC Pills empower women to take control of their reproductive health, without having to go to the doctor or rely on a partner to access birth control. Cultural attitudes also affect healthcare providers' behavior, prompting them to provide more information about over the counter (OTC) contraceptives. This makes OTC Pills more accessible because doctors and pharmacists support their use.

The market for over the counter (OTC) contraceptive Pills is expected to continue to grow as culture and attitudes change. Society's acceptance and support of effective family planning practices increases the need for affordable and effective contraceptives, which in turn increases the demand for OTC Pills among women who want more control over their fertility. As a result, demand for Over the Counter (OTC) market increases in the forecast period.

Government Supporting Policies and Regulations

Government supporting policies are one of the most important factors driving the OTC pill market. When the government revises regulations to allow prescription-only sale of some contraceptive Pills, it significantly improves the accessibility and availability of OTC Pills. By eliminating the prescription hurdle, women can easily access OTC Pills, which promotes responsible family planning, and reduces the number of unwanted pregnancies.

Supportive policies emphasize the importance of women's reproductive health and encourage healthcare professionals and pharmacists to promote and educate patients on over the counter (OTC) contraceptive options. The United States Food and Drug Administration (FDA) has granted a marketing authorization for Opill, a nonprescription oral contraceptive pill containing norgestrel, for the prevention of pregnancy. Opill is the first FDA-approved daily oral contraceptive pill for use in the United States without a prescription. The approval of this oral contraceptive pill containing progestin only allows consumers to buy oral contraceptive medicines without a prescription at pharmacies, convenience stores, grocery stores, and online pharmacies.

These policies also help to reduce the cost of contraceptive consultations, which makes birth control more accessible and attractive to the public. All in all, government support creates an environment conducive to the development of the over the counter (OTC) pill market, allowing women to make their own reproductive choices while supporting public health initiatives and family planning. This upsurges the growth of Over the Counter (OTC) Contraceptive Pills market in the coming years.

Surge In E-Commerce & Online Pharmacies

The surge in e-commerce and online pharmacies is playing a significant role in increasing the demand for Over-the-Counter (OTC) contraceptive pills globally. With the rise of digital platforms, consumers now have convenient access to a wide range of contraceptive products without the need for a prescription or in-person visit to a healthcare provider. Online pharmacies offer discreet and hassle-free shopping experiences, allowing individuals to browse, purchase, and have contraceptive pills delivered directly to their doorsteps. The anonymity provided by online platforms appeals to consumers who may feel uncomfortable discussing contraception in traditional healthcare settings. The availability of informational resources and customer reviews on e-commerce websites empowers individuals to make informed decisions about their contraceptive options. The convenience of online shopping and the ability to compare prices across different brands and formulations make OTC contraceptive pills more accessible and affordable to a broader audience. As a result, the surge in e-commerce and online pharmacies is driving the demand for OTC contraceptive pills globally, as individuals seek convenient and discreet solutions for family planning and reproductive health management.

Key Market Challenges

Counterfeit Products

The presence of counterfeit products in the market is a significant factor contributing to the decrease in demand for Over-the-Counter (OTC) contraceptive pills globally. Counterfeit contraceptive pills often mimic the appearance of genuine products, making it difficult for consumers to distinguish between authentic and fake medications. However, counterfeit pills may contain incorrect dosages, ineffective ingredients, or harmful substances, posing serious risks to users' health and safety. The proliferation of counterfeit products erodes consumer trust in OTC contraceptive pills, leading individuals to hesitate or refrain from purchasing these medications altogether out of fear of unknowingly consuming counterfeit pills. The negative publicity surrounding counterfeit incidents can tarnish the reputation of legitimate brands and the entire OTC contraceptive market, further dampening demand. The prevalence of counterfeit products may prompt regulatory agencies to impose stricter regulations or restrictions on OTC contraceptive pills, limiting their availability and accessibility to consumers. Efforts to combat counterfeit medications through enhanced regulatory oversight, enforcement measures, and consumer education campaigns are essential to mitigate the impact of counterfeit products on the demand for OTC contraceptive pills and ensure the safety and well-being of consumers globally.

Pricing Pressures

Pricing pressures are exerting a significant downward force on the demand for Over-the-Counter (OTC) contraceptive pills globally. While OTC contraceptive pills offer convenience and accessibility compared to prescription alternatives, their affordability remains a crucial factor influencing consumer purchasing decisions. However, the pricing of OTC contraceptive pills can vary widely depending on factors such as brand, formulation, packaging size, and distribution channel. In competitive markets, pricing pressures often drive manufacturers to lower prices to attract consumers, resulting in thinner profit margins for companies and potentially compromising product quality or marketing efforts. Conversely, in regions where OTC contraceptive pills are subject to high markups or taxes, the resulting higher prices may deter cost-conscious consumers from purchasing these products. Pricing pressures can exacerbate disparities in access to contraception, particularly for individuals with limited financial resources or inadequate insurance coverage. As a result, the prevalence of pricing pressures is decreasing the demand for OTC contraceptive pills globally, underscoring the need for affordable and accessible family planning options to ensure universal access to reproductive healthcare. Efforts to address pricing pressures through pricing reforms, subsidies, or cost-sharing arrangements are essential to alleviate financial barriers and stimulate demand for OTC contraceptive pills, improving reproductive health outcomes for individuals worldwide.

Key Market Trends

Continuous Research & The Development of New Products

Continuous research and the development of new products in the field of contraceptives are significantly increasing the demand for Over-the-Counter (OTC) contraceptive pills globally. As researchers strive to improve contraceptive options, innovations in formulation, delivery methods, and hormonal compositions are enhancing the efficacy, safety, and user-friendliness of contraceptive pills. New products offer benefits such as reduced side effects, increased convenience, and improved compliance, addressing the diverse needs and preferences of users. Advancements in contraceptive technology are expanding the range of available options, including extended-cycle pills, low-dose formulations, and non-hormonal alternatives, providing individuals with more choices to suit their individual circumstances and health concerns. Continuous research into contraceptive mechanisms and modes of action fosters confidence in the effectiveness and reliability of OTC contraceptive pills among consumers. The introduction of new products stimulates market competition, prompting existing brands to innovate and improve their offerings to remain competitive. Consequently, continuous research and the development of new products are driving the demand for OTC contraceptive pills globally, as individuals seek access to safe, effective, and convenient options for family planning and reproductive health management.

Increasing Prevalence of Online Consultation Services & Telemedicine

The increasing prevalence of online consultation services and telemedicine is significantly driving the demand for Over-the-Counter (OTC) contraceptive pills globally. With the rise of digital healthcare platforms, individuals now have easier access to virtual consultations with healthcare providers, allowing them to discuss their contraceptive needs and obtain prescriptions remotely. Telemedicine offers a convenient and discreet alternative to traditional in-person visits, particularly for individuals who may feel uncomfortable discussing reproductive health in face-to-face settings. The availability of online consultation services expands access to healthcare for individuals in underserved or remote areas, where healthcare facilities may be limited. Telemedicine enables healthcare providers to prescribe OTC contraceptive pills based on remote consultations, empowering individuals to access contraception without the need for physical appointments. Online pharmacies and e-commerce platforms facilitate the purchase and delivery of OTC contraceptive pills following virtual consultations, further streamlining the process for consumers. As a result, the increasing prevalence of online consultation services and telemedicine is driving the demand for OTC contraceptive pills globally, as individuals seek accessible, convenient, and confidential solutions for family planning and reproductive health management.

Segmental Insights

Pill Type Insights

Based on the Pill Type, in the global Over the Counter (OTC) Contraceptive Pills Market, combination pills, which contain both estrogen and progestin, have traditionally dominated due to their higher efficacy rates and added benefits. These combination pills not only provide effective contraception but also offer advantages such as regulation of menstrual cycles and reduction of menstrual cramps, providing women with added comfort and convenience.

However, progestin-only pills are gaining popularity in recent years, especially among women who cannot tolerate estrogens or who are breast-feeding. These pills present fewer risks for certain groups of women, making them a suitable alternative for those seeking contraception without the potential side effects associated with estrogen. With their increasing acceptance, progestin-only pills are becoming an important option in the contraceptive market, offering diverse choices and ensuring that women can find a method that suits their individual needs and preferences.

Regional Insights

The Global Over the Counter (OTC) Contraceptive Pills Market has been primarily dominated by the North American region. This dominance can be attributed to several key factors that contribute to the region's success in this market segment. North America boasts a well-established healthcare infrastructure, ensuring that individuals have easy access to healthcare services and resources. This facilitates the availability and distribution of contraceptive pills, making them readily accessible to the population. The high level of awareness regarding sexual health in North America plays a significant role in the market's growth. The region has made significant strides in promoting sexual health education and raising awareness about the importance of contraception. This has led to a more informed population, resulting in a higher demand for contraceptive options, including over the counter pills.

The availability of a wide variety of contraceptive options in North America has contributed to its market dominance. The region offers a range of choices to cater to different preferences and needs, allowing individuals to find the most suitable contraceptive method for them. This diverse range of options further drives the market's growth, as it ensures that individuals have access to a comprehensive selection of products. Initiatives and regulations in North America have been instrumental in supporting and promoting the accessibility of contraception. The region has implemented policies and programs that aim to remove barriers and improve access to contraceptive methods, including over the counter pills. These initiatives have created a favorable environment for the market's growth by ensuring that individuals have easy access to the contraceptive options they need.

Key Market Players

Mylan N.V.

Nurx Inc.

Everly Well, Inc.

Letsgetchecked Inc.

Uqora, Inc.

Hims & Hers Health, Inc.

Lemonaid Health, Inc.

Perrigo Company plc

Report Scope:

In this report, the Global Over the Counter (OTC) Contraceptive Pills Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Over the Counter (OTC) Contraceptive Pills Market, By Pill Type:

    Progestin Pills Combination Pills

Over the Counter (OTC) Contraceptive Pills Market, By Category:

    Generic Branded

Over the Counter (OTC) Contraceptive Pills Market, By Distribution Channel:

    Offline Online

Over the Counter (OTC) Contraceptive Pills Market, By Region:

    North America
    • United States
    • Canada
    • Mexico
    Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
    Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    South America
    • Brazil
    • Argentina
    • Colombia
    Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Over the Counter (OTC) Contraceptive Pills Market.

Available Customizations:

Global Over the Counter (OTC) Contraceptive Pills market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the study
  • 2.2. Baseline methodology
  • 2.3. Key industry partners
  • 2.4. Major association and secondary sources
  • 2.5. Forecasting methodology
  • 2.6. Data triangulation & validation
  • 2.7. Assumptions and limitations

3. Impact Of Covid-19 On Global Over the Counter (OTC) Contraceptive Pills Market

4. Executive Summary

  • 4.1. Overview of the market
  • 4.2. Overview of key market segmentations
  • 4.3. Overview of key market players
  • 4.4. Overview of key regions/countries
  • 4.5. Overview of market drivers, challenges, trends

5. Voice of Customer

6. Global Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Pill Type (Progestin Pills and Combination Pills)
    • 6.2.2. By Category (Generic and Branded)
    • 6.2.3. By Distribution Channel (Offline and Online)
    • 6.2.4. By Region
    • 6.2.5. By Company (2023)
  • 6.3. Market Map

7. North America Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Pill Type
    • 7.2.2. By Category
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Pill Type
        • 7.3.1.2.2. By Category
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. Canada Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Pill Type
        • 7.3.2.2.2. By Category
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Mexico Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Pill Type
        • 7.3.3.2.2. By Category
        • 7.3.3.2.3. By Distribution Channel

8. Europe Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Pill Type
    • 8.2.2. By Category
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Pill Type
        • 8.3.1.2.2. By Category
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. Italy Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Pill Type
        • 8.3.2.2.2. By Category
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. France Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Pill Type
        • 8.3.3.2.2. By Category
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Spain Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Pill Type
        • 8.3.4.2.2. By Category
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. United Kingdom Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Pill Type
        • 8.3.5.2.2. By Category
        • 8.3.5.2.3. By Distribution Channel

9. Asia-Pacific Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Pill Type
    • 9.2.2. By Category
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. China Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Pill Type
        • 9.3.1.2.2. By Category
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Japan Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Pill Type
        • 9.3.2.2.2. By Category
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. India Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Pill Type
        • 9.3.3.2.2. By Category
        • 9.3.3.2.3. By Distribution Channel
    • 9.3.4. Australia Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Pill Type
        • 9.3.4.2.2. By Category
        • 9.3.4.2.3. By Distribution Channel
    • 9.3.5. South Korea Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Pill Type
        • 9.3.5.2.2. By Category
        • 9.3.5.2.3. By Distribution Channel

10. Middle East and Africa Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Pill Type
    • 10.2.2. By Category
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. Middle East and Africa: Country Analysis
    • 10.3.1. UAE Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Pill Type
        • 10.3.1.2.2. By Category
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Pill Type
        • 10.3.2.2.2. By Category
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. South Africa Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Pill Type
        • 10.3.3.2.2. By Category
        • 10.3.3.2.3. By Distribution Channel

11. South America Over the Counter (OTC) Contraceptive Pills Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Pill Type
    • 11.2.2. By Category
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Pill Type
        • 11.3.1.2.2. By Category
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Argentina Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Pill Type
        • 11.3.2.2.2. By Category
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. Colombia Over the Counter (OTC) Contraceptive Pills Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Pill Type
        • 11.3.3.2.2. By Category
        • 11.3.3.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Merger & Acquisition (If Any)
  • 13.2. Product Launches (If Any)
  • 13.3. Recent Developments

14. Global Over the Counter (OTC) Contraceptive Pills Market: SWOT Analysis

15. Pestle Analysis

16. Porter's Five Forces Analysis

  • 16.1. Competition in the Industry
  • 16.2. Potential of New Entrants
  • 16.3. Power of Suppliers
  • 16.4. Power of Customers
  • 16.5. Threat of Substitute Products

17. Competitive Landscape

  • 17.1. Mylan N.V.
    • 17.1.1. Business Overview
    • 17.1.2. Company Snapshot
    • 17.1.3. Products & Services
    • 17.1.4. Financials (As Reported)
    • 17.1.5. Recent Developments
    • 17.1.6. Key Personnel Details
    • 17.1.7. SWOT Analysis
  • 17.2. Nurx Inc.
  • 17.3. Everly Well, Inc.
  • 17.4. Letsgetchecked Inc.
  • 17.5. Uqora, Inc.
  • 17.6. Hims & Hers Health, Inc.
  • 17.7. Lemonaid Health, Inc.
  • 17.8. Perrigo Company plc

18. Strategic Recommendations

19. About Us & Disclaimer